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Abstract
Background: The most efficient approach to diagnose malignant pleural effusions (MPEs) is still controversial and
uncertain. This study aimed to evaluate the utility of a combined approach using ultrasound (US)-guided cutting-needle
biopsy (CNB) and standard pleural biopsy (SPB) for diagnosing MPE.
Methods: Pleural effusions were collected from 172 patients for biochemical and microbiological analyses. US-guided
CNB and SPB were performed in the same operation sequentially to obtain specimens for histological analysis.
Results: US-guided CNB and SPB procedures provided adequate material for histological analysis in 90.7 and
93.0% of cases, respectively, while a combination of the 2 techniques was in 96.5% of cases. The sensitivity,
specificity, positive-predictive value (PPV), negative-predictive value (NPV) and diagnostic accuracy of US-guided CNB
versus SPB were: 51.2 vs 63.4%, 100 vs 100%, 100 vs 100%, 64.9 vs 72.2% and 74.4 vs 81.3%, respectively. When CNB
was combined with SPB, the corresponding values were 88.6, 100, 100, 88.6 and 93.9%, respectively. Whereas sensitivity,
NPV and diagnostic accuracy were not significantly different between CNB and SPB, the combination of CNB and SPB
significantly improved the sensitivity, NPV and diagnostic accuracy versus each technique alone (p < 0.05). Significant
pain (eight patients), moderate haemoptysis (two patients) and chest wall haematomas (two patients) were observed
following CNB, while syncope (four patients) and a slight pneumothorax (four patients) were observed following SPB.
Conclusions: Use of a combination of US-guided CNB and SPB afforded a high sensitivity to diagnose MPEs, it is a
convenient and safe approach.
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Background
Pleural effusions are a common clinical problem with
more than 50 recognised causes [1]. In the UK, an
estimated 50,000 diagnoses of MPE are made each year
[2]. While fluid tumor markers may help in making a
probable diagnosis of malignancy, they are not disease-
specific [3], and cytological examination of pleural fluid
for malignant cells establishes a positive diagnosis of
malignancy in only 60% of carcinomatous effusions [4–6].
Immunostaining substantially improves the diagnostic
yield [7] but this falls to 30% in effusions associated with
malignant mesothelioma [8]. Thus, the role and value of
fluid biomarkers and cytology are hotly debated [9].
The definitive diagnosis of pleural malignancy depends
upon histological proof obtained via pleural biopsy. SPB,
US-CNB and thoracoscopy are techniques commonly
utilised for the acquisition of pleural tissue [10–15].
Thoracoscopy has a superior diagnostic yield for pleural
effusions [16, 17] but it is relatively complicated to
perform, especially in frail patients. With the lower diag-
nostic yields, SPB and US-guided CNB are now being
neglected. However, given the ease of use of these pro-
cedure and their lesser costs, SPB or US-guided CNB
may be considered the initial diagnostic step in undiag-
nosed pleural effusions. Currently, the most efficient and
cost-effective approach for a definitive diagnosis remains
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difficult to establish and is controversial among chest
physicians [18].
To our knowledge, no prospective studies have been
undertaken to assess the utility of a combination of
US-guided CNB and SPB performed sequentially in the
same setting and by the same operator. Consequently, in
this prospective study, we evaluated the value of a combin-
ation of US-guided CNB and SPB for diagnosis of MPEs.
Methods
Study design and setting
We conducted a prospective, non-randomised study at a
dedicated respiratory centre (State Key Laboratory of Re-
spiratory Disease and China Clinical Research Centre of
Respiratory Disease, Guangzhou Institute of Respiratory
Disease, Guangzhou).
Patients
A total of 172 consecutive patients with pleural effusions
who were treated at our institution between January
2013 and December 2014 were included in the study.
The inclusion criteria for enrolment of patients were: (1)
undiagnosed and untreated pleural effusion; (2) unilat-
eral transudate as suggested by clinical images but unre-
solved upon treatment of the cause; and (3) age greater
than 18 years. Exclusion criteria included: (1) bilateral
pleural effusions; (2) minimal or small effusions; (3)
insufficient bleeding diathesis for pleural aspiration and
biopsy; and (4) an inability of the patient to provide
written informed consent.
Transthoracic ultrasound
All patients underwent initial conventional US scans
(Esaote Mylab 90, Italy) without previous removal of
pleural fluid. US was performed using splenic echotexture
as an in vivo reference. The patients were in a sitting,
prone, supine or lateral decubitus position when US was
performed. They were divided into two groups: those
exhibiting a maximum thickening of more than 3 mm,
and those exhibiting a maximum thickening of less than
3 mm. The presence of effusion was confirmed by stand-
ard means, and the amount of effusion was documented
as either minimal, small, moderate, or large [19]. All zones
were screened, and the information obtained via US was
used to select the entry site, route, sampling site, direction
of biopsy and the biopsy depth. The lower thoracic
parietal pleura close to the diaphragm was selected for
biopsy unless other regions of the parietal pleura were
thicker than the lower thoracic parietal pleura.
Diagnostic thoracentesis and US-guided cutting-needle
biopsy (CNB)
Prior to pleural biopsy, pleural effusions were collected
from all subjects for biochemical and microbiological
analyses, including pH, total protein, lactate dehydroge-
nases (LDH) and adenosine deaminase (ADA) levels. The
biopsy procedures were performed under real-time visual-
isation using a 16-gauge spring-loaded automated cutting
needle (MC1816, Bard Max-Core, Bard, Inc., USA) after
thoracentesis. The cutting needle was inserted through
the guiding channel and then introduced into the margin
of the pleural area. At least four specimens were obtained
from each patient, fixed in formaldehyde solution and
transferred to the Pathology Department for histological
examination and immunohistochemical analyses. One
specimen was placed in a sterile tube and sent for myco-
bacterial culture. Figures 1 and 2 show the images
obtained in two patients.
Standard pleural biopsy (SPB)
Following US-guided CNB, SPB (Abrams’ biopsy) was
performed at another site. For moderate effusions, the
biopsies were obtained from the site exhibiting the
maximum effusion as determined by US. In the case of
large effusions, the puncture site was chosen to be as
low as possible but not within 25 mm of the diaphragm.
To acquire a sufficient number of specimens, we created
one small incision (3–5 mm) on the skin; when neces-
sary, the parietal pleura was pressed to establish
complete contact with the biopsy needle. Collection of
biopsy specimens with SPB was similar to that with
US-guided CNB. In patients with large effusions, an in-
dwelling pleural catheter was inserted after conducting
all biopsy procedures to manage the subsequent steps
for a definitive diagnosis. A routine follow-up chest
x-ray was obtained within 24 h following the biopsy pro-
cedures to assess any possible complications.
All procedures were performed in a dedicated respira-
tory unit by an experienced physician (JW), and all US
procedures were performed by the same experienced
sonographer (XZ). The US patterns were evaluated by two
observers (JW and XZ). Disputes regarding pleural areas
were discussed until a consensus was reached. An experi-
enced lung pathologist evaluated the biopsy specimens.
Data analysis
A definitive diagnosis of pleural malignancy [true-posi-
tive (TP)] was made by histopathological analysis of the
biopsy specimens, clinical follow-up and surgery, while a
benign diagnosis [true-negative (TN)] was made if: (1)
the benign histological diagnosis was based on a precise
aetiology; (2) the pleural effusion subsequently disap-
peared; or (3) follow-up chest radiographs or computed
tomography (CT) scans showed a small amount of
pleural effusion that remained stable for at least
12 months. Patients with a benign histology were ob-
served for 12 months to minimise the risk of potential
false-negative (FN) results.
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Fig. 1 Images of a 42-year-old man with a history of shortness of breath for 1 month. a A conventional US scan showed an effusion and thickening of
the parietal pleura (0.18 cm). b Real-time US-guided cutting-needle biopsy (arrowhead) focused on the pleura and was introduced at an angle of 70°.
c A biopsy sample obtained from the pleura showed a tuberculoid nodule and caseous necrosis (H&E staining; magnification, × 10)
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Fig. 2 (See legend on next page.)
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We combined the two biopsy methods for each patient
and recognised a TP result if the two methods together
or each of the methods individually showed a TP result.
The patients’ clinical features, the characteristics of the
parietal pleura, pathology reports on the biopsy speci-
mens, the results of the cultured specimens, the defini-
tive diagnoses, and clinical outcomes were all recorded.
Statistical analysis
Data were reported as the number and percentage of
qualitative variables. Enumerated data were presented as
means ± standard deviation (SD). Categorical variables
were analysed and statistical analysis was performed
using SPSS® version 16.0 (IBM, Chicago, IL, USA). The
primary endpoint was the sensitivity of each biopsy
method (US-guided CNB or SPB) and the combination
of the two methods for detection of pleural malignancy.
Secondary endpoints were other elements of the deci-
sion matrix [(specificity, positive-predictive value (PPV),
negative-predictive value (NPV) and diagnostic accuracy
for pleural effusions)]. A χ2 test was used to compare
the adequacy of biopsy specimens, diagnostic sensitivity,
NPV and the diagnostic accuracy. Significance for all
statistical analyses was set at p < 0.05.
Results
Characteristics of patients and transthoracic US
Of the 172 patients who were enrolled in this study, 20
had undergone a non-diagnostic pleural aspiration
before visiting our institute, but none had previously
undergone pleural biopsy procedures. Table 1 shows the
demographic and pleural characteristics of the 172
patients; 80 exhibited moderate effusions while 92 had
large effusions. Thoracic CT scanning or US were used
to evaluate pleural thickening. Three patients had clear
bulky nodules (between 18 and 25 mm thick on the CT
scan), but 40 (23.3%) had no significant pleural thicken-
ing on the CT scan or US. Pleural thickness was less
than 3 mm in112 patients and greater than 3 mm in
60 patients.
Definitive diagnosis of the pleural effusions
The definitive diagnosis in 90 of the 172 enrolled
patients (52.3%) was pleural malignancy, while 82
(47.7%) had non-malignant disease as confirmed by the
clinical follow-up (Table 2, Additional file 1: Excel). Two
patients had identifiable micro-organisms in subsequent
analyses of their biopsy specimens. In six cases, the ma-
terial obtained with both biopsy techniques was
inadequate; four of these patients suffered from a disease
of indeterminate origin (as evidenced by more than
12 months of clinical follow-up), and the other two pa-
tients were diagnosed with lymphomas via thoracoscopy.
Combined SPB and US-guided CNB revealed FN results
in 10 cases. The final diagnoses for these patients were:
mesothelioma in four (as revealed by thoracoscopy);
adenocarcinoma in four [whose final diagnosis was de-
termined by transbronchial lung biopsy (TBLB)]; and
adenocarcinoma in two (who were also diagnosed with
pleural tuberculosis which was progressive during
follow-up when the final diagnosis was eventually made).
Definitive diagnosis analyses
Adequate pleural biopsy specimens for histological ana-
lysis were obtained in 156 patients (90.7%) with
US-guided CNB and 160 (93.0%) with SPB. The differ-
ence between the two techniques was not statistically
significant (p = 0.577). When US-guided CNB was com-
bined with SPB, adequate specimens were obtained in
166 patients (96.5%) using one or both techniques, but
the number of specimens obtained was not significantly
different from those obtained using US-guided CNB or
SPB alone (p = 0.119 or 0.304).
The sensitivities of US-guided CNB, SPB and a com-
bination of the two techniques for diagnosis of pleural
malignancy were 51.2, 63.4 and 88.6%, respectively
(Table 3). The combination of the two techniques
significantly improved the sensitivity compared with
each individual technique alone (p < 0.05), but there was
no significant difference in sensitivity between US-
guided CNB and SPB (p = 0.147). Significant differences
in the NPV and diagnostic accuracy were also observed
(See figure on previous page.)
Fig. 2 Images of a 54-year-old woman with a history of chest pain for 3 weeks. a A conventional US scan showed thickening of the lower thoracic parietal
pleura close to the diaphragm (0.15 cm) with a low echo texture. b Real-time US-guided cutting-needle biopsy (arrowhead) focused on the pleura and
was introduced at an angle of 70°. c Biopsy sample obtained from the pleura showed mesothelioma (H&E staining; magnification, × 100)
Table 1 Demographic and pleural characteristics of the patients
Parameter Value
Number of patients 172
Sex (M/F) 108/64
Age, years (mean ± SD; range) 54.8 ± 5.8 (22–91)





Pleural thickness <3 mm 112
Pleural thickness ≥3 mm 60
Data are numbers of patients unless otherwise stated
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between the combination and the individual techniques
alone (p < 0.05).
We also evaluated whether pleural thickness affected
the diagnostic accuracy of the two biopsy methods. In
patients with pleural thickening ≥3 mm, the diagnostic
accuracy with US-guided CNB and SPB were 84.2 and
82.5%, respectively, and the difference between the two
techniques was not statistically significant (p > 0.05).
However, in the group with pleural thickening <3 mm,
diagnostic accuracy was significantly greater with SPB
than with US-guided CNB (p < 0.05).
With US-guided CNB, the diagnostic accuracy was sig-
nificantly greater in patients with pleural thickening ≥3 mm
in comparison with those with pleural thickening <3 mm
(p < 0.05), but with SPB, there was no statistically significant
difference the two pleural thickening groups (p > 0.05). The
findings of this analysis are shown in Table 4.
Complications
The two biopsy procedures were generally well tolerated,
and neither procedure was abandoned because of com-
plications. With US-guided CNB, 8 of the 172 patients
suffered from significant pain during the procedure and
four of these patients required parenteral analgesics.
Two moderate haemoptyses and two chest wall haema-
tomas were observed in four patients following
US-guided CNB, but none required further intervention.
Following SPB, four patients experienced syncope, but
none required any specific medical intervention and all
recovered fully within 1 min. In addition, four patients
suffered from a slight pneumothorax following SPB;
these cases were suspected on the basis of US post-
biopsy results and were confirmed by chest x-ray, which
stopped spontaneously without treatment.
One patient who was diagnosed with a mesothelioma
showed an implantation metastasis in the CNB incision
after 3 months of follow-up.
Discussion
The definitive diagnosis of pleural diseases, particularly
malignancy, depends upon histological analysis of tissue
obtained via pleural biopsy. Adequate pleural tissues,
which are crucial for a definitive diagnosis, can be ob-
tained by SPB, thoracoscopy or CNB under the guidance
of CT or US. Thoracoscopy allows direct visualisation of
the pleura and biopsy from abnormal sites [20]. In a
study of patients with pleural tuberculosis, Koegelenberg
et al [21]. found that US-assisted Abrams’ needle biopsy
specimens were more likely to contain pleural tissue
than specimens obtained using US-assisted Tru-Cut bi-
opsies (91.0 vs 78.7%; p = 0.015). In 2014, Hallifax et al
[22]. reported that US-guided CNB successfully obtained
pleural tissue in a high proportion of patients (94.0%)
with pleural disease, including cases where thoracoscopy
had failed. The present study is the first prospective in-
vestigation of a combination of US-guided CNB and
SPB for the diagnosis of MPE. Our results showed that
US-guided CNB and SPB provided adequate specimens
for histological analysis in 90.7 and 93.0% of cases, re-
spectively (p = 0.577), while the combination of both
techniques provided adequate specimens in 96.5% of
Table 3 Comparison of diagnostic accuracy between US-guided biopsy and standard biopsy
CNB (n = 156) SPB (n = 160) CNB + SPB (n = 166) Statistical significance
FN 40 30 10 NA
TN 74 78 78 NA
TP 42 52 78 NA
FP 0 0 0 NA
Sensitivity 51.2% 63.4% 88.6% p = 0.147, 0.000, 0.000*
Specificity 100% 100% 100% NA
PPV 100% 100% 100% NA
NPV 64.9% 72.2% 88.6% p = 0.394, 0.000, 0.009*
Diagnostic accuracy 74.4% 81.3% 93.9% p = 0.341, 0.001, 0.017*
CNB cutting-needle biopsy, FN false-negative, FP false-positive, NA not applicable, NPV negative-predictive value, PPV positive-predictive value, SPB standard pleural
biopsy, TN true-negative, TP true-positive, US ultrasound
*p-values for CNB vs SPB; CNB + SPB vs CNB; and CNB + SPB vs SPB
Table 2 Final diagnoses of the causes of pleural effusions in
172 patients
Malignant neoplasms No. Non-malignant disease No.
Adenocarcinoma 42 Inflammatory pleuritis 16
Squamous cell carcinoma 12 Pleuritis fibrosis and plaques 6
Mesothelioma 10 Pleural tuberculosis 44
Lymphoma 4 Fungal infection 4
Pleural metastasis of
breast cancer
4 Chronic empyema 6
Undifferentiated cell
carcinoma
2 Indeterminate origin disease 4
Small lung cancer 16 Chronic heart failure 2
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cases; however, the latter result was not significantly
superior to the two techniques alone (p = 0.119 or 0.304).
Current guidelines on the investigation of pleural effu-
sions emphasise the use of a diagnostic algorithm or rec-
ommend the use of a stepwise approach [6, 23–25].
However, pleural effusion analyses and biomarkers are not
disease-specific [3, 26–28]. Previous biopsy investigations
have mostly focused on the advantages and limitations of
each individual technique, and to our knowledge, no stud-
ies have investigated a combination of CNB and SPB at
the same time. Our results indicate that a combination of
the two techniques is more effective than either technique
alone for the diagnosis of malignant pleural disease. The
size of this advantage is considerable. The combination of
CNB and SPB led to a correct diagnosis of MPE in 88.6%
of patients, and the sensitivity (88.6%) was only slightly
lower than published sensitivities from large thoracoscopy
series [29, 30]. Thoracoscopy has the advantage of under-
taking some therapeutic options, such as talc poudrage, at
the same time, but has the disadvantages of being more
costly, more invasive, and hazardous in very frail patients.
The combination of CNB and SPB performed sequentially
by same operator in the same setting can avoid the need
for repeated procedures (since the sensitivities of the
combination of US-guided CNB and SPB and the two
techniques alone for diagnosis of pleural malignancy were
88.6, 51.2 and 63.4%, respectively, 37 or 25% of patients
compared with CNB or SPB alone could avoid the need
for repeated procedures), and it would decrease both
medical costs and the time required for evaluation of
pleural malignancy.
SPB was described more than 50 years ago and
became the most widely utilised method for blind biopsy
[31]. This procedure has some advantages, including a
relatively low cost and ease of usage, but it generally
demonstrates a modest diagnostic accuracy of less than
60% for MPE [5, 6],although a higher diagnostic accur-
acy for pleural tuberculosis (80–87%) [17, 32]. In recent
years, US-guided CNB has been increasingly used for
pleural biopsy. The most obvious advantage of this pro-
cedure is its ability to ensure that biopsy samples are
obtained from areas characterised by abnormal pleural
tissue. While US-guided CNB increases the diagnostic
accuracy and minimises the risk compared with SPB
[33, 34], its diagnostic accuracy is lower than that of
thoracoscopy [6, 35]. However, the use of thoraco-
scopy is not always possible in frail patients or when
pleural fluid is heavily loculated or the lung is adher-
ent to the chest wall.
To overcome these limitations, a combination of CNB
and SPB was used in this study. All procedures were
performed sequentially by an experienced operator (JW)
according to standardised guidelines. Several possible
factors could be responsible for the diagnostic advantage
of the combination in comparison with the individual
techniques. During SPB, an incision in the skin in the dir-
ection of the chosen intercostal space above the lower rib
was made, especially in overweight/obese patients. During
the biopsy procedure, the assistant pressed the skin
between the ribs, which allowed the distal tip of the needle
to have sufficient contact with the pleura. A limitation of
SPB is the blindness of the procedure, although an experi-
enced operator can obtain adequate tissues for a
histological diagnosis. We found that the number of
adequate specimens was higher with SPB than with
CNB (93.0 vs 90.70%, respectively), and, as previously
reported [17, 32–36], the diagnostic accuracy was also
higher (81.3 vs 74.4%, respectively). In addition, for
patients with a pleural thickness <3 mm, the diagnos-
tic accuracy of SPB was also significantly higher than
with CNB (p < 0.05).
For CNB, we performed the procedures using relatively
supradiaphragmatic biopsy sites or the most thickened
pleural sites. Pleural malignancy is characteristically
patchy and preferentially basal, or is found on the dia-
phragm and results in focal involvement [36]. In addition,
a large angle may be essential to obtain adequate samples,
especially from thin pleura. The cutting needle was
cautiously introduced at an angle of more than 55°
through an incision in the skin made toward the direction
of the chosen intercostal space under the guidance of a
high-frequency probe. However, as has previously been
reported [17, 32–36], our results showed that the diagnos-
tic accuracy of CNB was lower than that of SPB (74.4 vs
81.3%, respectively). When our results were analysed
according to the degree of pleural thickening, the diagnos-
tic accuracy of CNB in patients with pleural thickening
<3 mm was significantly lower than in patients with
pleural thickening ≥3 mm (p < 0.05), and significantly
lower than with SPB (p < 0.05). A possible reason for this
Table 4 Diagnostic accuracy of the 2 biopsy techniques according to the degree of pleural thickening in US scans
Pleural
thickening
CNB (n = 156) SPB (n = 160) p-Value
No. Accuracy (%) No. Accuracy (%)
≥3 mm 57 49 (84.2) 57 47 (82.5) 0.607 (χ2 = 0.264)
<3 mm 99 67 (67.6) 103 83 (80.6) 0.036 (χ2 = 4.398)
p-Value 0.012 (χ2 = 6.345) 0.771 (χ2 = 0.085)
CNB cutting-needle biopsy, SPB standard pleural biopsy
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finding may be that the diagnostic accuracy is affected by
pleural thickening. When a US-guided pleural biopsy is
performed in patients with minor pleural thickening, there
may be a lower probability of obtaining adequate speci-
mens. However, SPB may be capable of acquiring a larger
number of adequate samples.
Both biopsy procedures were well tolerated in the
patients we studied, and no serious complications were
observed. However, we concerned with that although four
significant pain and two moderate haemoptysis required
no intervention, there were about 3.5% complications
(four significant pain and two chest wall haematoma)
required further intervention following CNB. Following
SPB, four patients (2.3%) suffered from a slight pneumo-
thorax, but which recovered spontaneously. Though
neither procedure was abandoned for the complication,
management must be to improve to avoid it, such as, bet-
ter preparation for reducing syncope or significant pain,
skilled procedures for avoiding haemoptysis, chest wall
haematoma or pneumothorax. Reported complication
rates of SPB or image-guide CNB vary widely [16, 37, 38].
There was 11% had a new pneumothoraces visible on CT
following CT-guided CNB [38], but major complication
was rare. Thoracoscopy has demonstrated a low rate of
complications, but mortality rates resulting from major
complications (including air leak and pneumonia) have
been reported to be 0.34–1.8% [2, 39]. So, the combined
approach was safe. In addition, compared with the sug-
gested stepwise approach and thoracoscopy [6, 16], the
combination was finished in the same operation sequen-
tially, it shortened the days of hospitalization, decreased
the cost and it was convenience. In our study, one patient
was found to have an implantation metastasis at the
biopsy site after 3 months of follow-up. Whether prophy-
lactic radiotherapy of the site can reduce the likelihood of
this complication is controversial [4, 40].
Conclusions
Use of a combination of US-guided CNB and SPB
afforded a high sensitivity to diagnose MPEs, it is a con-
venient and safe approach.
Additional file
Additional file 1: Excel: Detailed results of CNB, SPB, CNB or SPB of the
17 2 UPE patients. (XLS 33 kb)
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